Navigation Links
Arthrosurface® Hits the 20,000 Implant Milestone

FRANKLIN, Mass., May 24 /PRNewswire/ -- Arthrosurface, Inc. (, the developer of inlay joint resurfacing systems, announced the achievement of a significant clinical milestone.  Over 20,000 patients, typically middle aged, have been treated with the various Arthrosurface cartilage resurfacing systems, with the early patients now 6 years post surgery.

"Back in 2003, there was no accepted surgical 'next step' for those patients that had exhausted conservative & biological therapies such as drug injections & microfracture.  With the passing of the 20,000 patient milestone and with more than 98% of the implants still in place, we have achieved our initial goal of providing a less invasive option that would allow patients to go back to an active lifestyle while delaying the need for a joint replacement," commented Steven Ek, COO.

"For very advanced disease in the older aged patient, joint replacement still provides a good option.  However, the baby boomer population has been the silent sufferer.  They have joint pain, limited mobility and all the signs of early articular cartilage damage. In my opinion, a well accepted treatment for early disease in the boomer population does not exist.  Having the Arthrosurface technology as an interim treatment has provided a great new option for these patients," remarked Anthony Schepsis, MD, Professor of Orthopaedic Surgery at Boston University.  "For me and thousands of other surgeons, this system has been a very effective solution for those patients that have failed early treatments and yet are too young for a total joint replacement. The Arthrosurface system has filled this gap in my sports medicine practice."

The Arthrosurface inlay resurfacing technology was developed to treat the young and active patient typically referred to as the baby boomer.  The company's technology uses a family of implants with different shapes and sizes to effectively recreate the patient's joint geometry with an intraoperative 3D mapping instrument set.  Arthrosurface has been a leader in introducing anatomic inlay resurfacing in the knee, shoulder and toe.  The company's focus remains dedicated to early joint resurfacing for the boomer population. The company's systems are indicated and FDA cleared for use in the knee, shoulder, hip and toe.

SOURCE Arthrosurface, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
2. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
3. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
4. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
5. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
6. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
7. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
10. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
11. First Human Implant of New Archus Orthopedics Facet Replacement System
Post Your Comments:
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):